Civic AI
Procurement intelligence
Federal contract award
NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
HEALTH DECISIONS, INC. · Department of Health and Human Services
- Value
- $233,291
- Start
- Aug 1, 2025
- End
- Aug 30, 2026
- Action date
- Mar 18, 2026
- PIID
- 75N94025F00002
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- DURHAM, NC
- Award type
- DELIVERY ORDER
Description
NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Need modifications, related awards, and vendor peers? Open the full award workspace.